Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Operating Leases (2021 - 2025)

TransMedics (TMDX) has 5 years of Operating Leases data on record, last reported at $4.4 million in Q3 2025.

  • For Q3 2025, Operating Leases fell 37.42% year-over-year to $4.4 million; the TTM value through Sep 2025 reached $4.4 million, down 37.42%, while the annual FY2024 figure was $6.2 million, 18.92% down from the prior year.
  • Operating Leases reached $4.4 million in Q3 2025 per TMDX's latest filing, down from $4.9 million in the prior quarter.
  • Across five years, Operating Leases topped out at $8.6 million in Q4 2021 and bottomed at $4.4 million in Q3 2025.
  • Average Operating Leases over 5 years is $7.1 million, with a median of $7.3 million recorded in 2022.
  • Peak YoY movement for Operating Leases: rose 5.71% in 2023, then crashed 37.42% in 2025.
  • A 5-year view of Operating Leases shows it stood at $8.6 million in 2021, then fell by 13.82% to $7.4 million in 2022, then rose by 3.94% to $7.7 million in 2023, then decreased by 18.92% to $6.2 million in 2024, then decreased by 29.17% to $4.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Leases were $4.4 million in Q3 2025, $4.9 million in Q2 2025, and $5.5 million in Q1 2025.